Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Air Ambulance Costs Soar Despite Limited Use in Workers Compensation
Air ambulance transports remain rare in workers‑comp claims, affecting fewer than 1.2% of rural lost‑time cases, yet they dominate cost drivers. Average payments have surged more than 60% since 2013, topping $25,000 per flight by 2022. Utilization spikes in very rural areas and states like Texas, while California sees the highest per‑transport bills, exceeding $50,000. Divergent state regulations and the Airline Deregulation Act create wide payment gaps, prompting heightened payer scrutiny.
Introducing a Group-Based Cannabis Prevention Program for Adolescents in Youth Residential Care in Germany (CANJuStop): Study Protocol for an Exploratory...
A new group‑based cannabis prevention program, CAN Ju Stop, is being tested among adolescents in German residential youth care. The exploratory cluster‑randomized trial compares the adapted six‑session intervention with a waitlist control, measuring abstinence or reduction in cannabis use over 30 days....
5 of the Top 10 U.S. Health Systems Are Moving to This New Health IT Category. Here’s Why.
Health systems have built fragmented AI "agent" stacks that operate on isolated data slices, leading to mis‑aligned decisions and limited impact. The core issue is a lack of unified context across clinical, financial and operational information. Innovaccer’s Gravity platform introduces...
How Starkey Is Staying Ahead of the AI Hearing-Aid Wave
Starkey has been embedding artificial intelligence into its hearing‑aid portfolio since 2017, turning a single‑purpose device into a multi‑function, personalized sound platform. The company claims its AI can tailor audio for each user, giving it a technological edge over newer...
Iraqi Medicaid Swindler Who Claimed Defense Department Clearances Flees Maine for Turkmenistan $1M Richer: The Maine Wire
Maine’s Medicaid program, MaineCare, has been plagued by home‑health fraud, with dozens of agencies siphoning millions from taxpayers. Mostafa Alahmedi, president of 5 Star Home Health Care, claimed a secret‑level security clearance while operating a ghost office that overbilled the state...
Continuity of Care in the Age of AI: Supporting Safer Handovers in Primary and Community Health and Social Care
A new human‑centred AI framework aims to reduce handover failures in UK primary, community and social care. The four‑component model includes change‑focused summaries, cross‑team communication support, safety prompts, and workforce wellbeing integration. A needs assessment of 21 domiciliary care workers...
FastFinance: Health System Capex Plans; Medicare IPPS Impacts
HFMA’s FastFinance newsletter has launched a podcast hosted by Rich Daly, highlighting key healthcare finance trends. Hospitals and health systems are scaling back capital expenditures in 2026, reallocating funds to different priorities. Rural hospitals remain under pressure, with 34.9% operating...
Replimune Looks Ahead as Repeat CRL Speeds the Company's Decline
Replimune received a second complete response letter (CRL) from the FDA for its lead oncolytic cancer therapy, citing additional data gaps and manufacturing concerns. The regulatory setback triggered a wave of layoffs affecting roughly 30% of its workforce and pushed...
Max Hodak’s Science Corp. Is Preparing to Place Its First Sensor in a Human Brain
Science Corp, the neurotechnology startup founded by former Neuralink president Max Hodak, has recruited Yale neurobiologist Murat Günel as a scientific adviser to oversee its first U.S. human trials of a bio‑hybrid brain‑computer interface. The company recently closed a $230 million Series C...
DaVita Algorithm Flags Issues With Home Dialysis Patients
DaVita Kidney Care has deployed a predictive machine‑learning tool, the Peritoneal Dialysis Loss Model, to monitor home dialysis patients. By analyzing roughly 150 data points—including vitals, lab results and machine‑generated alerts—the system flags the riskiest 10% of patients for early...
Artificial Intelligence Is Changing Medical Writing Today
Artificial intelligence is rapidly becoming a staple in medical writing, helping clinicians draft, edit, and synthesize research faster than ever. Yet many writers feel a lingering shame, treating AI assistance as a secret and even disguising their prose to appear...
MusiCares Launches Digital Suicide Prevention Resources For Artists, Music Community
MusiCares, the Recording Academy’s charitable arm, has launched a digital hub with The Jed Foundation to provide suicide‑prevention and mental‑health resources tailored for music professionals. The site debuted on April 14 following the 2025 MusiCares Wellness In Music Survey, which found...
Zuri Health Expands Mobile Clinic Fleet Across High-Traffic Nairobi
Zuri Health, the Kenya‑based health‑tech startup, has added two more solar‑powered mobile clinic buses, bringing its fleet to three operating in Nairobi. Two of the buses serve as self‑contained clinics offering diagnostics, dental care and cervical cancer screening, while the...
RBM20 Genetic Variants Linked to Arrhythmogenic Dilated Cardiomyopathy
A large cohort study using UK Biobank, All of Us, and an international registry shows that RBM20 gene variants contribute to arrhythmogenic dilated cardiomyopathy (DCM). While pathogenic missense RBM20 variants are linked to severe disease, truncating RBM20 variants present later...
NEW STUDY: Frog-Derived Gut Bacterium Completely Eradicates 100% of Tumors After a Single Dose in Mice
A peer‑reviewed study in *Gut Microbes* reports that a single intravenous dose of the frog‑derived gut bacterium Ewingella americana eradicated colorectal tumors in 100% of immunocompetent mice. The live microbe outperformed both doxorubicin chemotherapy and anti‑PD‑L1 checkpoint blockade, achieving complete...
Shawn Davis, MD, on Access, Coverage, and the Future of Obesity Therapy
The FDA’s approval of oral semaglutide (Rybelsus) was hailed as a breakthrough for obesity treatment, yet uptake has lagged as patients on injectable GLP‑1s show little interest in switching to a daily pill. Early market confusion stemmed from the drug’s...
WHO Unveils Global Curriculum Guide for Community Health Workers
The World Health Organization released a Global Curriculum Guide for community health workers and a step‑by‑step integration manual on April 15, 2026. The resources are intended to standardize training, strengthen primary health care, and help ministries coordinate CHW programmes.
Novo Nordisk Says Weight Loss Is Not a Straight Line in New Guidance
Novo Nordisk posted new guidance on its official Facebook page, stressing that weight loss rarely follows a straight path and encouraging patients to adjust plans and consult healthcare professionals. The company highlighted the role of FDA‑approved medicines and personalized support...
The 2026 MDO Medtech Startups Special Report
Medical Design & Outsourcing released its 2026 Medtech Startups Special Report, a free guide packed with technical tips and strategic advice for early‑stage medical device companies. The report highlights a tightening fundraising environment as venture capital pours into AI and...
Neuralink Shifts to Speech‑Focused Brain‑Computer Interface Trials, Raising Viability Questions
Neuralink announced new speech‑restoration clinical trials at the University of Texas Southwestern Medical Center and Cleveland Clinic Abu Dhabi, moving away from its long‑standing motor‑cursor interface. The pivot follows criticism that its original brain‑computer interface (BCI) strategy lags behind competitors...
Child Psychiatrist Jailed for Sexual Abuse of Teen Has Registration Cancelled by High Court
The Irish High Court ordered the permanent cancellation of child psychiatrist Amirul Mohd Yunos’s medical registration after he pleaded guilty to multiple sexual offences involving a teenage girl. Yunos, who worked at a CAMHS centre in Clonskeagh, is serving an 8½‑year...
China Launches AI‑Powered Digital Doctor for Parkinson’s, Aiming to Cut 90% Routine Queries
Xuanwu Hospital of Capital Medical University in Beijing has rolled out China’s first AI‑driven digital doctor platform for Parkinson’s disease. Built on two decades of clinical data, the service claims it can answer up to 90% of routine patient questions,...
Dialysis Industry Faces Scrutiny as Consolidation Fuels Profit Over Patient Care
A new investigative report highlights how two firms—DaVita and Fresenius Medical Care—control almost 80% of US dialysis centers, inflating prices and prompting a 2025 antitrust lawsuit. The piece underscores disproportionate impacts on Black Americans, who comprise 35% of dialysis patients...
Knowledge, Perception and Reporting Attitudes of Adverse Events Following Immunization Among Parents of Infants in Rural Area, Sri Lanka: A...
A cross‑sectional survey of 393 parents in rural Sri Lanka found 73% had adequate knowledge of adverse events following immunization (AEFI), but only 48% could identify serious reactions such as anaphylaxis. Knowledge was higher among parents over 30, with secondary...
After Three Years of Conflict, Sudan Faces a Deeper Health Crisis
After three years of war, Sudan now faces the world’s largest humanitarian crisis, with 34 million people needing aid and 21 million lacking health services. Disease outbreaks—including malaria, dengue, measles, polio and cholera—are spreading across 18 states, while 37% of health facilities...
FDA Grants Full Approval to Travere’s FILSPARI for FSGS, Unlocking $2B Market
Travere Therapeutics announced that the FDA has granted full approval to FILSPARI (sparsentan) for focal segmental glomerulosclerosis (FSGS) without nephrotic syndrome. The decision makes FILSPARI the first approved therapy for the rare kidney disease and expands the drug’s addressable U.S....
In the Clinic for April 14, 2026
The "In the clinic for April 14, 2026" page serves as a centralized hub that aggregates the latest Bioworld data snapshots, special reports, and infographics across biopharma, medical technology, and emerging therapeutic areas. It links to analyses on mRNA vaccine...
Breast Milk’s Living Stem Cells May Reach Infant Brain
Breast milk contains living stem cells. In animal studies, these cells survived digestion in newborns, entered the bloodstream, and were found in multiple tissues including the brain. Whether this happens in humans is still being studied, but the animal data...
J&J’s Cardiovascular Unit Stands Out Again in Q1
Johnson & Johnson’s medtech division is accelerating a strategic shift toward high‑growth cardiovascular and surgical‑robotics markets, backed by roughly $30 billion in recent acquisitions. In Q1 2026 the cardiovascular unit posted 13% growth, generating $2.38 billion, while Abiomed and Shockwave revenues rose...
New CellCelector CLD Takes You From Thousands of Candidates to the Top Clone, Faster
German biotech equipment maker Sartorius has launched the CellCelector CLD, an automated imaging and cell isolation platform that accelerates monoclonal cell line development. The system combines high‑speed scanning, advanced imaging and gentle clone retrieval to screen up to 885 nanowell...
Gaps in Persistence, Coverage Limit GLP-1 Impact in Obesity
Two AMCP 2026 posters highlighted persistent gaps in GLP‑1 therapy for obesity. A claims‑based analysis of 53,183 patients showed persistence falling from 65% at 120 days to 34% at one year, with higher out‑of‑pocket costs and fewer clinician visits driving...
BHV-2100
Researchers from KU Leuven, CISTIM Leuven and Biohaven Therapeutics have announced that an oral TRPM3 antagonist has entered Phase 2 clinical testing for the acute treatment of migraine. The program leveraged a cell‑based high‑throughput screen of more than 200,000 compounds to...
The Future of MedTech Field Execution Is Agentic
Salesforce’s Agentforce Life Sciences for Customer Engagement redefines medtech field execution by embedding AI into the daily workflow of representatives. The platform transforms reps from data‑laden administrators into insight‑driven clinical consultants, cutting the average 40% of time spent on paperwork....
Medical Claims Require Trials, Not AI Hype
-AI has nothing to do with it. You are selling bullshit. If your AI can determine which person ‘needs’ which peptide, you will need a trial to show that. -Palantir has nothing to do with it - You can sell...
Nvidia's Nurabot Deploys in Hospitals to Aid Staff
Nvidia’s Nurabot Rolls Into Hospitals to Assist #Healthcare Workers by @CyberRobooo #MedTech #HealthTech #TechForGood #Tech https://t.co/DFb98tjoM4
Johnson & Johnson’s Spravato Sales Growth Signals Upside for Psychedelics Peers
Johnson & Johnson reported Spravato generated $468 million in Q1 2026, a 46% year‑over‑year increase that translates to an annualized run rate above $1.9 billion. Quarterly sales slipped 7% versus the prior quarter due to seasonal insurance resets, but the company reaffirmed guidance...
GLP‑1 Drugs Show Weight‑loss‑independent Benefits, Study Finds
Great work by @DanielJDrucker and team; biologically plausible mechanism of GLP1-RA benefit independent of weight loss. Excellent article by @megtirrell @CNN describing the publication. Could it justify new approaches for these drugs? I think so. https://t.co/pHudk7lkAR
Taxes Fund Elderly's Cruise‑bound Diabetes Medication
Your taxes largely exist to pay for the diabetes drugs old people take while on their cruises.
50 Employees Impacted as Astellas Closes Universal Cells' Seattle Office
Tokyo‑based Astellas Pharma announced the closure of Universal Cells' Seattle office, affecting 50 employees. A handful of staff will be transferred to Astellas’ research sites in South San Francisco and Westborough, while the remainder face layoffs in waves from July...
Shared Visibility, Not Contracts, Aligns Care Ecosystem
Alignment doesn’t come from contracts. It comes from shared visibility. Why smart-care platforms are becoming the bridge between payers, providers, and post-acute care.👇 https://t.co/cq0WY5tihP @PointClickCare #postacutecare #HITSM
Novo Partners OpenAI as Ideaya's Eye Data Disappoints
Novo teams with OpenAI; Ideaya gets muted response to eye drug data https://t.co/U6sDZlMxyQ $NVO $IDYA $REGN $GSK
Attacks on Medical Facilities During War Demand Global Response
Recent WHO data cited by the BMJ show 43 attacks on health facilities in Iran and Lebanon since late February, killing dozens of health workers and crippling hospitals. These assaults breach the Geneva Conventions, which guarantee medical neutrality even as...
Classic Lymphadenopathy Differential Diagnosis Table Highlights Key Features
Lymphadenopathy [2000] Habermann & @DavidSteensma @MayoProceedings https://t.co/56RvIsHEG3 <- a classic esp DDx Table 3 #lymsm #hemeonc https://t.co/PlvEKQVoiG
Unexplained Splenomegaly Study Reveals Preliminary Findings
The Challenge of Unexplained Splenomegalies: Preliminary Data of the French Prospective Multi-Center Splenomegaly Study (SMS) [Nov 29, 2018] Guillaume Denis, MD etal. @BloodJournal 32 (Supplement 1): 4815 #ASH18 https://t.co/N0PeoI1agT #SMUS
What Patients Should Know Before Choosing a Dentist in Sunshine Coast
Sunshine Coast residents are shifting from reactive to preventive dental care, emphasizing long‑term oral health, patient comfort, and transparent treatment planning. Clinics in Maroochydore, Cotton Tree, Mooloolaba and Buderim now offer a full suite of services—from routine cleanings to implants—under...
SMART Permission Tickets Enable Seamless Patient and Proxy Access
How might SMART Permission Tickets help with patient self-access, proxy access, public health, and more? Overview / explainer / live demo here: https://t.co/AHJ8s5oBuA
Comprehensive Genomic Panel Broadens Oncology Treatment Options
Unique Features of a Comprehensive Genomic Profiling Panel: Expanding Treatment Options in a Value-Based Community Oncology Network [Mar 9, 2026] La Porte et al. @DrEzraCohen @JCOPO_ASCO https://t.co/tDi3kbxdvX #PrecisionMedicine #hemeonc @TempusAI https://t.co/zgEw8hfFia
Tuesday Health Partners with Humana on Palliative Care
Tuesday Health, a 2023 startup backed by Valtruis and Mass General Brigham Ventures, has partnered with Humana to launch a value‑based palliative‑care program for Texas members on June 1. The initiative offers coordinated clinical guidance, proactive symptom management and continuous support...
Real-World Data Reveal Molecular Profile of Metastatic ILC
Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity [Sep 10, 2025] Davis et al. @CCR_AACR https://t.co/eY0etUfQhQ #bcsm #PrecisionMedicine #camoldx @TempusAI https://t.co/oDkC1Ua6DS
Somatic Immune Cell Mutations Linked to Autoimmunity
New evidence that somatic mutations in immune cells can be the basis for autoimmune disease @Nature https://t.co/GvzxLYgvfw